Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
25%

OVERLAP
BY WEIGHT
33

# OF OVERLAPPING
HOLDINGS
CANC
52
HOLDINGS
62%
ALSO IN XBI
XBI
139
HOLDINGS
25%
ALSO IN CANC
SECTOR DRIFT (CANC minus XBI)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in XBI
Overlap
ARCELLX, INC. 3.6% 1.7% 1.7%
REVOLUTION MEDICINES, INC. 5.9% 1.6% 1.6%
CG ONCOLOGY, INC. 2.2% 1.5% 1.5%
AMGEN INC 2.4% 1.5% 1.5%
CELCUITY INC. 3.2% 1.4% 1.4%
CANC Overweight Relative to XBI
NOVARTIS AG 4.5%
ASTRAZENECA PLC 4.4%
REVOLUTION MEDICINES, INC. 4.3%
ELI LILLY & CO 4.2%
ROCHE HOLDINGS LTD-SPONS ADR 4.0%
BRISTOL-MYERS SQUIBB CO 3.6%
MERCK & CO. INC. 3.5%
GENMAB A/S SPONSORED ADR 2.9%
IMMUNOME, INC. 2.7%
BRIDGEBIO PHARMA, INC. 2.6%
CANC Underweight Relative to XBI
MODERNA, INC. -2.3%
ROIVANT SCIENCES LTD. -1.8%
VAXCYTE, INC. -1.6%
AMICUS THERAPEUTICS INC -1.6%
MIRUM PHARMACEUTICALS, INC. -1.5%
UNITED THERAPEUTICS CORP -1.4%
BIOMARIN PHARMACEUTICAL INC -1.4%
VERTEX PHARMACEUTICALS INC -1.3%
KRYSTAL BIOTECH, INC. -1.3%
EXACT SCIENCES CORP -1.3%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY